Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -1.65%205.11M | -41.64%257.18M | 28.56%236.57M | 40.45%195.5M | -4.68%208.55M | 0.40%440.68M | -6.25%184.01M | 4.04%139.19M | 11.32%218.8M | -2.71%438.91M |
Transactional financial assets | 12,459.68%100.44M | 33,746.20%270.68M | -73.43%211.38K | -3.97%609.89K | -44.27%799.74K | -43.90%799.74K | -55.06%795.57K | -98.78%635.11K | -98.73%1.44M | -98.30%1.43M |
Notes receivable and accounts receivable | -13.12%895.89M | -16.80%780.79M | -3.40%1.05B | -0.15%1.09B | 2.62%1.03B | 4.51%938.46M | 9.52%1.09B | 13.74%1.09B | 10.60%1B | 14.61%897.99M |
-Accounts receivable | -13.12%895.89M | -16.80%780.79M | -3.40%1.05B | -0.15%1.09B | 2.62%1.03B | 4.51%938.46M | 9.52%1.09B | 13.74%1.09B | 10.60%1B | 14.61%897.99M |
Other receivables (including interest and dividends) | 7.33%23.05M | 5.69%25.52M | 4.39%20.36M | -7.84%19.92M | 15.82%21.47M | -6.43%24.15M | -33.78%19.5M | -5.34%21.62M | -40.01%18.54M | 45.12%25.81M |
-Other receivable | ---- | 5.69%25.52M | ---- | -7.84%19.92M | ---- | -6.43%24.15M | ---- | -5.34%21.62M | ---- | 45.12%25.81M |
Advance payment | 70.01%21.64M | -21.44%6.15M | -10.17%11.83M | -19.72%12.7M | -20.46%12.73M | 11.29%7.83M | -20.95%13.17M | 5.52%15.82M | -17.27%16M | 6.57%7.04M |
Inventories | -11.42%68.14M | -7.45%60.69M | -4.65%105.09M | 2.57%90.83M | 4.44%76.93M | 3.24%65.58M | 17.16%110.22M | 24.43%88.55M | 117.94%73.66M | 96.81%63.52M |
Assets held for sale | 814.48%43.06M | 814.48%43.06M | --0 | ---- | --4.71M | 1,076.63%4.71M | --0 | ---- | ---- | --400.18K |
Other current assets | 2,967.39%573.26K | 2,433.34%573.26K | -79.46%5.1K | -99.59%3.07K | 13.30%18.69K | -87.85%22.63K | -94.92%24.84K | 1.63%744.44K | -94.47%16.49K | -41.11%186.22K |
Total current assets | 0.11%1.36B | -2.54%1.44B | 0.66%1.42B | 3.78%1.41B | 1.73%1.36B | 3.27%1.48B | 6.27%1.41B | 8.18%1.36B | 2.35%1.33B | 4.36%1.44B |
Non Current assets | ||||||||||
Other equity investment | ---- | ---- | --0 | ---- | ---- | ---- | -86.19%1.93M | -86.19%1.93M | -86.19%1.93M | -86.19%1.93M |
Other non-current financial assets | -51.54%217.73M | -51.54%217.73M | 0.15%449.3M | 0.15%449.3M | 0.15%449.3M | 0.15%449.3M | -0.68%448.64M | -0.68%448.64M | -0.68%448.64M | -0.68%448.64M |
Investment real estate | -3.17%60.16M | -3.15%60.65M | -3.13%61.14M | -3.10%61.64M | -3.08%62.13M | -3.05%62.62M | -3.67%63.11M | -3.70%63.61M | -3.82%64.1M | -3.80%64.59M |
Long-term equity investment | -26.63%368.09M | -26.04%375.24M | -4.68%500.64M | -4.40%503.13M | -3.36%501.68M | -3.28%507.33M | -4.14%525.23M | -3.82%526.3M | -7.63%519.13M | -6.99%524.52M |
Fixed assets | ---- | -13.81%639.63M | ---- | -2.43%724.96M | ---- | -1.52%742.08M | ---- | -2.90%743.02M | ---- | 2.69%753.56M |
Constru in process | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%4.71M | ---- | -89.59%4.71M |
Intangible assets | -18.67%4.48M | -14.45%4.97M | -26.62%4.62M | -3.36%5.06M | -1.09%5.5M | 2.00%5.81M | 56.96%6.3M | 30.39%5.24M | 34.90%5.56M | 84.69%5.69M |
Goodwill | ---- | ---- | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M | 0.00%7.05M |
Long deferred expense | -24.62%5.47M | -36.31%5.09M | -38.51%4.83M | -12.58%6.3M | -5.23%7.26M | -1.93%7.99M | 82.14%7.85M | 148.17%7.21M | 150.71%7.66M | 93.64%8.14M |
Deferred tax assets | 120.26%37.65M | 99.25%30.59M | -56.53%15.26M | -53.60%14.78M | -49.79%17.1M | -36.52%15.35M | 46.05%35.1M | 35.82%31.85M | 74.89%34.05M | 53.71%24.19M |
Usufruct assets | -29.34%23.36M | -31.73%24.24M | -31.96%25.82M | -31.27%27.76M | -8.60%33.06M | -8.51%35.51M | -8.42%37.95M | -8.35%40.39M | -22.54%36.18M | -21.34%38.81M |
Other non current assets | 72.21%1.58M | 56.06%1.01M | --1.64M | --1.19M | --917.14K | --646.44K | ---- | ---- | ---- | ---- |
Total non current assets | -25.57%1.35B | -25.88%1.36B | -5.06%1.79B | -4.19%1.8B | -3.36%1.82B | -2.56%1.83B | -2.28%1.88B | -2.61%1.88B | -3.54%1.88B | -3.75%1.88B |
Total assets | -14.59%2.71B | -15.44%2.8B | -2.60%3.21B | -0.85%3.21B | -1.24%3.17B | -0.04%3.32B | 1.21%3.3B | 1.64%3.24B | -1.18%3.21B | -0.40%3.32B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | --50M | --50M | ---- | ---- |
Notes payable and accounts payable | 9.81%4.57M | -55.80%4.98M | -42.64%3.75M | 115.21%3.74M | 76.61%4.16M | 30.51%11.28M | 233.02%6.53M | -35.39%1.74M | 14.07%2.36M | 231.53%8.64M |
-Accounts payable | 9.81%4.57M | -55.80%4.98M | -42.64%3.75M | 115.21%3.74M | 76.61%4.16M | 30.51%11.28M | 233.02%6.53M | -35.39%1.74M | 14.07%2.36M | 231.53%8.64M |
Contract liabilities | 98.07%15.41M | 30.54%13.21M | 0.17%5.13M | 59.60%8.08M | 28.30%7.78M | 82.62%10.12M | 81.62%5.12M | -2.36%5.06M | -9.93%6.07M | -35.73%5.54M |
Advance receipts | 124.01%355.79K | 62.82%150.41K | 47.45%383.23K | 62.69%160.6K | 6.91%158.83K | -95.40%92.38K | 88.42%259.9K | -33.38%98.72K | -66.07%148.56K | 388.98%2.01M |
Salaries payable | -1.17%103.02M | -4.45%116.15M | -9.00%97.99M | -11.51%99.54M | -7.18%104.24M | 14.54%121.56M | 6.04%107.68M | 16.91%112.49M | 60.08%112.31M | 9.73%106.13M |
Taxs payable | -11.87%83.38M | -12.32%90.28M | -5.18%102.07M | -6.05%100.87M | -3.82%94.61M | 0.41%102.96M | 6.05%107.64M | 7.56%107.37M | 7.31%98.37M | 8.92%102.55M |
Other payable (including interest and dividends) | -73.07%3.76M | -56.15%7.88M | -56.21%13.72M | 42.01%43.8M | -54.63%13.97M | -47.73%17.98M | -44.36%31.33M | -47.64%30.84M | -39.31%30.79M | -41.34%34.4M |
-Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --43.75K | --39.38K | ---- | ---- |
-Dividend payable | ---- | ---- | ---- | --30.04M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | -56.15%7.88M | ---- | -55.34%13.76M | ---- | -47.73%17.98M | ---- | -47.71%30.8M | ---- | -41.34%34.4M |
Non current liabilities due within one year | -50.57%3.66M | -55.48%3.62M | -62.69%3.06M | -53.83%4.17M | 27.24%7.41M | 19.76%8.14M | 1.32%8.19M | -9.99%9.03M | -45.16%5.82M | -25.06%6.8M |
Other current liabilities | 124.13%1.1M | 48.59%970.47K | 11.06%334.48K | 72.45%522.4K | 34.17%489.18K | 92.18%653.11K | 56.32%301.17K | -19.99%302.93K | -32.37%364.59K | -46.70%339.84K |
Total current liabilities | -7.54%215.27M | -13.03%237.26M | -28.58%226.44M | -17.69%260.88M | -9.13%232.83M | 2.40%272.79M | 16.33%317.07M | 15.93%316.94M | 9.99%256.23M | -1.64%266.41M |
Current liabilities | ||||||||||
Deferred tax liabilities | ---- | ---- | -64.08%13.21M | -53.81%16.98M | -62.60%13.75M | -40.10%22.03M | 0.00%36.77M | -0.10%36.77M | -0.21%36.77M | -0.17%36.77M |
Lease liabilities | -18.11%23.3M | -19.30%24.23M | -16.41%26.68M | -19.59%27.26M | -11.31%28.46M | -10.51%30.03M | -7.99%31.91M | -3.50%33.9M | -13.07%32.09M | -14.74%33.56M |
Total non current liabilities | -44.79%23.3M | -53.45%24.23M | -41.93%39.88M | -37.40%44.24M | -38.70%42.21M | -25.98%52.06M | -3.88%68.68M | -1.76%70.67M | -6.64%68.86M | -7.70%70.33M |
Total liabilities | -13.26%238.57M | -19.50%261.49M | -30.96%266.32M | -21.28%305.13M | -15.39%275.04M | -3.53%324.85M | 12.13%385.75M | 12.24%387.61M | 5.99%325.08M | -2.97%336.73M |
Shareholders equity | ||||||||||
Paid-in capital | -0.01%751M | -0.01%751M | -0.01%751.08M | -0.01%751.08M | -0.01%751.08M | -0.01%751.08M | -0.05%751.17M | -0.05%751.17M | -0.05%751.17M | -0.05%751.17M |
Capital reserve funds | 0.04%1.65B | 0.08%1.65B | 0.14%1.65B | 0.21%1.65B | 0.28%1.65B | 0.35%1.65B | 0.56%1.65B | 0.66%1.65B | 0.80%1.65B | 0.95%1.64B |
Surplus reserve funds | 0.00%153.41M | 0.00%153.41M | 4.99%153.41M | 4.99%153.41M | 4.99%153.41M | 4.99%153.41M | 5.67%146.12M | 5.67%146.12M | 5.67%146.12M | 5.67%146.12M |
Retained profit | -110.53%-41.45M | -94.29%27.54M | 1.79%438.28M | 8.67%398.04M | -3.21%393.52M | -2.96%482.23M | -4.19%430.58M | -2.17%366.27M | -15.58%406.55M | -4.14%496.94M |
Less:Treasury stock | ---- | ---- | -64.28%10.09M | -64.56%10.09M | -64.56%10.09M | -64.56%10.09M | -41.82%28.25M | -42.03%28.47M | -42.03%28.47M | -42.03%28.47M |
Other composite income | 0.00%-21.04M | 0.00%-21.04M | -10.10%-21.04M | -10.10%-21.04M | -10.10%-21.04M | -10.10%-21.04M | -170.36%-19.11M | -170.36%-19.11M | -170.36%-19.11M | -170.36%-19.11M |
Ordinary risk reserve funds | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M | 0.00%1.99M |
Shareholders equity without minority interests | -14.53%2.5B | -14.74%2.56B | 1.14%2.97B | 2.05%2.93B | 0.52%2.92B | 0.49%3.01B | 0.21%2.93B | 0.66%2.87B | -1.56%2.9B | 0.34%2.99B |
Minority interests | -11.22%-23.85M | -31.96%-22.48M | 0.51%-21.65M | -21.37%-21.32M | -31.31%-21.44M | -30.40%-17.03M | -62.84%-21.76M | -99.19%-17.57M | -206.95%-16.33M | -10,655.60%-13.06M |
Total shareholder equity | -14.72%2.47B | -15.00%2.54B | 1.15%2.94B | 1.93%2.9B | 0.35%2.9B | 0.36%2.99B | -0.08%2.91B | 0.35%2.85B | -1.93%2.89B | -0.11%2.98B |
Total liabilityies and equity | -14.59%2.71B | -15.44%2.8B | -2.60%3.21B | -0.85%3.21B | -1.24%3.17B | -0.04%3.32B | 1.21%3.3B | 1.64%3.24B | -1.18%3.21B | -0.40%3.32B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Zhonglian Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.